Octreotide-conjugated silver nanoparticles for active targeting of somatostatin receptors and their application in a nebulized rat model
Open Access
- 23 December 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Nanotechnology Reviews
- Vol. 11 (1) , 266-283
Abstract
Drug uptake and distribution through cell–receptor interactions are of prime interest in reducing the adverse effects and increasing the therapeutic effectiveness of delivered formulations. This study aimed to formulate silver nanoparticles (AgNPs) conjugated to somatostatin analogs for specific delivery through somatostatin receptors (SSTRs) expressed on cells and by nebulizing the prepared AgNPs formulations into lung cells for in vivo application. AgNPs were prepared using the citrate reduction method, yielding AgNPs–CTT, which was further chemically conjugated to octreotide (OCT) to form AgNPs–OCT through an amide linkage. The AgNPs–OCT formulation was coated using alginate to yield a carrier, AgNPs–OCT–Alg, feasible for drug delivery through nebulization. AgNPs were uniform in size with an acceptable range of zeta potential. Furthermore, the concentrations of AgNP formulations were found safe for the model cell lines used, and cell proliferation was significantly reduced in a dose-dependent manner ( p < 0.05). In the healthy lung tissues, AgNPs–OCT–Alg accumulated at a concentration of 0.416 ± 5.7 mg/kg tissue , as determined via inductively coupled plasma optical emission spectrometry. This study established the accumulation of AgNPs, specifically the AgNPs–OCT–Alg, in lung tissues, and substantiated the active, specific, and selective targeting of SSTRs at pulmonary sites. The anticancer efficacy of the formulations was in vitro tested and confirmed in the MCF-7 cell lines. Owing to the delivery suitability and cytotoxic effects of the AgNPs–OCT–Alg formulation, it is a potential drug delivery formulation for lung cancer therapy in the future.Keywords
This publication has 77 references indexed in Scilit:
- Biopersistence of silver nanoparticles in tissues from Sprague–Dawley ratsParticle and Fibre Toxicology, 2013
- Deposition behavior of inhaled nanostructured TiO2in rats: fractions of particle diameter below 100 nm (nanoscale) and the slicing bias of transmission electron microscopyInhalation Toxicology, 2012
- The stoichiometry of the Escherichia coli Hfq protein bound to RNARNA, 2011
- Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar ratsToxicology Mechanisms and Methods, 2010
- Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549Archives of Toxicology, 2010
- SRBC/cavin‐3 is a caveolin adapter protein that regulates caveolae functionThe EMBO Journal, 2009
- Bone-protective Effects of Nonviral Gene Therapy With Folate–Chitosan DNA Nanoparticle Containing Interleukin-1 Receptor Antagonist Gene in Rats With Adjuvant-induced ArthritisMolecular Therapy, 2008
- Biology of somatostatin in breast cancerMolecular and Cellular Endocrinology, 2008
- Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian CellsNano Letters, 2006
- Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathologyBreast Cancer Research and Treatment, 2005